Skip to main content

Elastomeric Closure Components Market by Roots Analysis

 

To order this detailed 400+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/elastomeric-closures-market-focus-on-parenteral-containers-2019-2030/255.html

 

Key Inclusions

§  A detailed assessment of the current market landscape of companies manufacturing elastomeric container closures, featuring information on the type of closure (cap, needle shield, plunger, seal, stopper, and tip cap), type of respective primary container(s) (vial, syringe, and cartridge), elastomeric material(s) used for fabricating the aforementioned closures (such as bromobutyl, chlorobutyl, and others), drug type(s) that are compatible with elastomeric closures, sterilization status of closures (pre-sterilized and unsterilized), affiliated sterilization technique (if the closure(s) is available in the pre-sterilized format), scale of production (small scale, and large scale), type of customization (if available), affiliated dimensions, along with compliance certifications of the product.

§  A comprehensive analysis on the packaging trends of over 230 drug products (including both biologics and small molecule drugs) that were approved over the last five years (beginning 2014), featuring an assessment of the packaging requirements of various container-closure systems based on parameters, such as year of approval of drug, type of molecule, dosage form, route of administration, holding temperature, type of packaging material(s) used for manufacturing primary container and affiliated closure, and leading drug developers (in terms of number of drugs packaged using elastomeric closures).

§  An analysis of various developments / recent trends related to elastomeric packaging materials, offering insights on [A] partnerships and collaborations established within the industry, and [B] recent global conferences related to pharmaceutical packaging industry.

§  Elaborate profiles of key players in this domain (shortlisted on the basis of size of product portfolio), featuring a brief overview of the company (including information on company headquarters, year of establishment, number of employees, and key members of the executive team), financial information (if available), detailed description of proprietary elastomeric closures, recent developments, and an informed future outlook.

§  A case study on the role of robotics in pharmaceutical manufacturing and fill / finish operations, highlighting the advantages of using automation / automated technologies in such processes. It includes profiles of industry players offering such equipment for the aseptic processing of pharmaceutical products.

§  An elaborate discussion on emerging trends (such as focus on personalized therapies, shift towards more flexible packaging, upgrading packaging components to enhance drug product safety, and growing adoption of smart packaging solutions) that are likely to have an impact on the future adoption of elastomeric container-closure components in the pharmaceutical packaging industry. It also features a Harvey ball analysis, highlighting the relative effect of each trend on the overall pharmaceutical packaging industry.

§  An in-depth analysis to estimate the current and future demand for elastomeric closures across key primary packaging containers, including vials, syringes and cartridges, in different regions for the period 2019-2030. Input parameters considered for this analysis include current supply of different primary packaging components and their respective closures and the estimated the proportion of elastomeric closures that are likely to be supplied, which is indicative of the demand.

 

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:

 

§  Type of packaging container

§ Vials

§ Syringes

§ Cartridges

 

§  Type of packaging closure

§ Seal

§ Stopper

§ Cap

§ Plunger

§ Barrel

§ Needle Shield

 

§  Sterilization status

§ Pre-sterilized

§ Unsterilized

 

§  Key geographical regions

§  North America

§  Europe

§  Asia Pacific

§  Rest of the World

 

To request sample pages, please visit this - https://www.rootsanalysis.com/reports/255/request-sample.html

 

Key Questions Answered

§  What are the popular types of elastomeric materials and coatings being used for the fabrication of closures for parenteral containers (vials, ampoules and syringes)?

§  What are the types of drugs which require elastomeric closures to ensure minimize the risk of extractables and leachables?

§  Who are the leading manufacturers of elastomeric closures across the globe?

§  What is the relative popularity of various types of elastomeric materials used for the packaging of different closure types?

§  How do parameters such as dosage form, route of administration and storage temperature of drugs, influence choice of elastomeric closures?

§  What is the proportion of closures available in pre-sterilized format in the market?

§  What are the popular sterilizing techniques used for pre-sterilization of closures?

§  What are the key drivers of partnership activity in this industry?

§  What are the key challenges associated with the manufacturing of elastomeric components?

§  What are the key considerations for choosing materials for fabricating closures?

§  What are the benefits of pre-sterilized closures? Who are the key players that offer pre-sterilized container-closure kits / systems?

§  Which are latest innovations in the field of elastomeric packaging materials?

§  What is the current and future demand for parenteral containers and their respective closures from 2019 to 2030? 

§  What are the key factors that are likely to influence the evolution of the elastomeric closures market?

§  How is the current and future market opportunity likely to be distributed across key market segments and geographies?

 

You may also be interested in the following titles:

1.     Medical Device Contract Manufacturing Market, 2019-2030

2.     Biologics Fill / Finish Services Market, 2019 – 2030  

3.     Pre-Sterilized / Ready-to-Use Primary Packaging: Focus on Cartridges, Syringes and Vials, 2018-2030

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

 

Comments

Popular posts from this blog

NOVEL DRUG RECONSTITUTION SYSTEMS - CURRENT MARKET LANDSCAPE

  Over the years, novel drug reconstitution systems have been widely adopted in the healthcare sector, owing to the numerous benefits offered by these products. During our research, we identified over 55 novel drug reconstitution systems , including prefilled syringes, cartridges and infusion bags being manufactured to ease the reconstitution of drugs packaged in containers. To order this detailed 180+ page report, please visit this - https://www.rootsanalysis.com/reports/drug-reconstitution-systems-market.html     Majority of the companies (32%) engaged in this domain are very large players. Examples of such companies include ( in alphabetical order, established after 1900 ) Baxter, Fresenius Kabi, ICU Medical, Shandong Pharmaceutical Glass, Terumo, Vetter Pharma and West Pharmaceutical Services. This is followed by the share of mid-sized players (29%) in this domain. P rominent examples of mid-sized players include ( in alphabetical order, established after...

Manufacturing Market Continuous by Roots Analysis

    Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing   Roots Analysis is pleased to announce the publication of its recent study, titled, “ Manufacturing Market Continuous (Small Molecules and Biologics), 2020 – 2030 .”   The report features an extensive study of the current market landscape and future opportunities for companies with capabilities in continuous manufacturing (both innovator companies with in-house expertise and contract manufacturers). It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes: §   A detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing §   Elaborate profiles of some o...

Digital Health Market: Focus on Digital Therapeutics by Roots Analysis

  Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions   Roots Analysis has announced the addition of “ Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030 (Based on Type of Solution (Software Solution, Gaming Solution and Combination Solution), Type of Therapy (Curative and Preventive), and Purpose of Solution (Medication Replacement and Medication Augmentation” report to its list of offerings.   According to experts, digital therapeutic solutions are primarily based on behavior modification and are designed to address a variety of therapeutic needs across a wide range of disease indications. On the other hand, several digital solutions have been developed to enable remote doctor-patient consultations. Such solutions witnessed a surge in ado...